Friday, 24 January 2020

Korea News

  • DB Schenker opens new logistics center in Korea

    Korea |  News | By BioSpectrum Bureau  | 0 Comment | 18 Jul, 2013

    Singapore: As part of its strategy to further build global supply chain competence in the healthcare market, Germany-based DB Schenker has opened a new logistics center in South Korea to pr...Read more

  • ICON partners with Korean national clinical trials enterprise

    Korea |  News | By BioSpectrum Bureau  | 0 Comment | 09 Oct, 2012

    Singapore: ICON, a global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries, and Korea National Enterprise for Clinical Trials ...Read more

  • New laser to deliver drugs painlessly

    Korea |  News | By BioSpectrum Bureau  | 0 Comment | 17 Sep, 2012

    Singapore: A new type of drug delivery system has been devised, which uses an erbium-doped yttrium aluminium garnet laser to propel a precise stream of medicine with the correct amount of f...Read more

  • Which domain of clinical research do APAC CROs focus on?

    Korea |  Analysis | By BioSpectrum Bureau  | 0 Comment | 18 Sep, 2013

    The fifth edition of the annual BioSpectrum Asia Pacific clinical research organization (CRO) Survey, which is conducted in association with CyberMedia Research (CMR), yet again identifie...Read more

  • IVI appoints new board members

    Korea |  Influencers | By BioSpectrum Bureau  | 0 Comment | 20 Nov, 2013

    Singapore: South Korea-headquartered International Vaccine Institute (IVI) has appointed Professor Fred Binka, Dr Joseph J Kim, and Dr George R Siber, to the IVI board of trustees. The thr...Read more

  • Foot and Mouth disease outbreak in South Korea

    Korea |  News | By BioSpectrum Bureau  | 0 Comment | 24 Apr, 2014

    fsdfs...Read more

  • Celltrion files for Remsima approval in Japan

    Korea |  News | By BioSpectrum Bureau  | 0 Comment | 17 Sep, 2013

    Singapore: Korea-based Celltrion has completed filing procedure of biosimilar drug Remsima to obtain Japan's Ministry of Health, Labour and Welfare (MHLW) approval. Remsima is a biosimilar...Read more

  • South Korean drug firms look overseas for profit

    Korea |  News | By BioSpectrum Bureau  | 0 Comment | 05 Aug, 2013

    Singapore: In a bid to generate new profit engines, South Korean pharmaceutical companies have set their eyes on overseas markets. As per data generated by the Korea Pharmaceutical Manufac...Read more

  • SNUH integrates OmniComm solutions for clinical trial data

    Korea |  News | By BioSpectrum Bureau  | 0 Comment | 04 Apr, 2014

    Singapore: OmniComm Systems, a provider of clinical data management solutions for clinical trials, has signed a five year agreement with Seoul National University Hospital (SNUH) Clinical T...Read more

  • Pfizer trial of cancer drug INLYTA is a failure

    Korea |  News | By BioSpectrum Bureau  | 0 Comment | 22 Oct, 2012

    Singapore: Pfizer has revealed that its phase III study of INLYTA (axitinib) did not meet the primary endpoint of demonstrating statistically significantly longer progression-free survival ...Read more

  • Korea to improvise Jordan healthcare system

    Korea |  News | By BioSpectrum Bureau  | 0 Comment | 07 Jul, 2014

    Singapore: Korean International Cooperation Agency (KOICA) signed a memorandum of understanding with the Ministry of Health for establishment and expansion of health centers in Jordan. The ...Read more

  • Malaysian firm Duopharma forays into biosimilars

    Korea |  News | By BioSpectrum Bureau  | 0 Comment | 01 Aug, 2012

    Singapore: Malaysia's chemical company Duopharma has tied up with Korea's PanGen Biotech to pioneer a clinical trial of Erythropoietin (EPO) in Malaysia to treat end stage renal failure pat...Read more

  • AstraZeneca, KHIDI setup cancer research program

    Korea |  News | By BioSpectrum Bureau  | 0 Comment | 11 Mar, 2014

    Singapore: AstraZeneca signed a memorandum of understanding (MoU) with the Korea Health Industry Development Institute (KHIDI) to set up an oncology research programme. AstraZeneca will pro...Read more

  • US biosimilars market to be $9 bn by 2020

    Korea |  News | By BioSpectrum Bureau  | 0 Comment | 03 Oct, 2012

    Singapore: A new report by global business intelligence firm GBI Research has highlighted that the massive potential for pharmaceuticals in the US means that the country's biosimilars marke...Read more

  • Will RNL stem cell drug trial get Korean FDA nod?

    Korea |  Regulatory | By BioSpectrum Bureau  | 0 Comment | 12 Feb, 2013

    Singapore: RNL Bio filed an Investigational New Drug (IND) application with the Korean Food and Drug Administration (KFDA) to start phase II and III clinical trials of RNL-Astrostem stem ce...Read more

  • Samsung to make Roche biologics at Korean plant

    Korea |  News | By BioSpectrum Bureau  | 0 Comment | 24 Oct, 2013

    Singapore: Samsung BioLogics and Roche have entered into a long term strategic manufacturing agreement under which Samsung will manufacture Roche's proprietary commercial biologic medicines...Read more

  • RNL to license stem cell technology to in Turkey

    Korea |  News | By BioSpectrum Bureau  | 0 Comment | 14 Sep, 2012

    Singapore: RNL Bio has signed the agreement with RST Biomedikal Sanayi, a Turkish company, to license RNL Bio's stem cell technology. RST as a licensee will pay the $5 million fee upfront ...Read more

  • Stem cells can help prevent Alzheimer's disease

    Korea |  News | By BioSpectrum Bureau  | 0 Comment | 27 Sep, 2012

    Singapore: In the first study of its kind, researchers at one of Korea's leading university and the RNL Bio Stem Cell Technology Institute have found that adult stem cells may not only have...Read more



Survey Box

Is 2020 demanding timely action of technology adoption in healthcare?

× Please select an option to participate in the poll.
Processing...   View poll results   More polls

× You have successfully cast your vote.
{{ optionDetail.option }}{{ optionDetail.percentage }}%
{{ optionDetail.percentage }}% Complete
More polls